TAG-1 A2 is a peptide variant designed to study antigen presentation and MHC-binding preferences. The sequence includes anchor residues contributing to peptide-MHC stability and conformational integrity. Researchers use it to examine epitope positioning, solvent exposure, and structural determinants of recognition. Its defined motif supports immunological and biophysical analysis.
CAT No: ta-529
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More